Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
3.34
Dollar change
+0.14
Percentage change
4.37
%
Index- P/E- EPS (ttm)-0.49 Insider Own53.59% Shs Outstand48.92M Perf Week9.87%
Market Cap163.39M Forward P/E- EPS next Y-0.07 Insider Trans1.24% Shs Float22.71M Perf Month-25.78%
Income-16.29M PEG- EPS next Q- Inst Own3.42% Short Float3.18% Perf Quarter32.02%
Sales0.43M P/S379.98 EPS this Y77.55% Inst Trans- Short Ratio1.13 Perf Half Y212.15%
Book/sh0.33 P/B10.03 EPS next Y36.36% ROA-76.31% Short Interest0.72M Perf Year413.85%
Cash/sh0.16 P/C20.66 EPS next 5Y- ROE-124.73% 52W Range0.28 - 4.97 Perf YTD86.59%
Dividend Est.- P/FCF- EPS past 5Y- ROI-92.70% 52W High-32.76% Beta5.15
Dividend TTM- Quick Ratio1.85 Sales past 5Y0.00% Gross Margin24.35% 52W Low1092.86% ATR (14)0.36
Dividend Ex-Date- Current Ratio1.85 EPS Y/Y TTM-245.19% Oper. Margin-3704.63% RSI (14)45.35 Volatility7.23% 10.36%
Employees76 Debt/Eq0.13 Sales Y/Y TTM- Profit Margin-3761.03% Recom1.00 Target Price5.50
Option/ShortNo / Yes LT Debt/Eq0.08 EPS Q/Q-141.87% Payout- Rel Volume0.71 Prev Close3.20
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume637.59K Price3.34
SMA20-6.95% SMA50-8.63% SMA20066.37% Trades Volume455,744 Change4.37%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Initiated H.C. Wainwright Buy $3.25
Apr-12-24 09:53AM
Apr-11-24 08:00AM
Apr-09-24 08:49AM
Apr-08-24 09:22AM
Apr-03-24 07:00AM
07:00AM Loading…
Apr-02-24 07:00AM
Apr-01-24 08:00AM
Mar-06-24 07:00AM
Mar-05-24 07:00AM
Feb-29-24 08:30AM
Feb-22-24 01:49PM
Feb-18-24 08:00PM
Feb-16-24 05:47PM
Feb-07-24 07:00AM
Feb-06-24 07:00AM
01:10PM Loading…
Jan-19-24 01:10PM
Jan-12-24 09:15AM
Jan-10-24 08:30AM
Dec-06-23 07:00AM
Dec-05-23 07:00AM
Nov-27-23 08:00AM
Nov-24-23 09:00AM
Oct-29-23 07:35PM
Oct-27-23 09:00AM
08:00AM
Oct-20-23 09:00AM
Oct-19-23 08:00AM
Oct-09-23 08:20AM
Oct-04-23 07:00AM
Oct-03-23 08:30AM
07:00AM Loading…
07:00AM
Sep-28-23 08:00AM
Aug-08-23 07:00AM
Jul-05-23 06:46AM
Jun-27-23 08:30AM
Jun-16-23 09:00AM
May-30-23 07:00AM
May-12-23 09:00AM
May-08-23 09:29AM
Apr-18-23 07:00AM
Apr-12-23 07:07AM
Apr-10-23 07:35AM
Mar-21-23 07:00AM
Mar-17-23 05:00PM
10:30AM
08:15AM
Mar-15-23 08:25AM
07:10AM
Mar-13-23 08:00AM
Mar-08-23 08:00AM
Nov-29-22 07:00AM
Nov-28-22 09:00AM
Nov-25-22 08:30AM
Nov-21-22 08:45AM
Nov-15-22 02:00PM
Nov-10-22 07:30AM
ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ryan Robert John AndrewDirectorJan 29 '24Buy2.3515,59636,651537,055Feb 26 07:27 AM
Ryan Robert John AndrewDirectorJan 25 '24Buy2.54100254521,459Feb 26 07:27 AM
Ryan Robert John AndrewDirectorJan 17 '24Buy1.91100191521,359Feb 26 07:27 AM
Ryan Robert John AndrewDirectorJan 16 '24Buy1.922,5504,896521,259Feb 26 07:27 AM
Donfeld Joshua JayDirectorOct 26 '23Buy0.96104,167100,0001,104,167Oct 30 09:50 PM
Moore DuncanDirectorOct 26 '23Buy0.96104,167100,000854,167Oct 30 09:51 PM
Wider ToddDirectorOct 26 '23Buy0.9694,84491,050494,844Oct 30 09:51 PM
Moore DuncanDirectorJun 29 '23Buy0.50100,00049,990550,000Jul 03 07:04 AM
Moore DuncanDirectorMay 18 '23Buy0.3120,0006,230450,000May 19 04:05 PM
Moore DuncanDirectorMay 10 '23Buy0.5010,0005,000430,000May 16 08:09 AM